2022 Q1 Form 10-Q Financial Statement

#000156032722000050 Filed on May 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $157.4M $151.6M $117.5M
YoY Change 34.0% 33.96% 24.5%
Cost Of Revenue $51.29M $49.88M $36.29M
YoY Change 41.33% 48.01% 30.94%
Gross Profit $106.1M $101.8M $81.16M
YoY Change 30.72% 28.0% 21.82%
Gross Profit Margin 67.41% 67.11% 69.1%
Selling, General & Admin $96.66M $82.34M $71.20M
YoY Change 35.77% 20.56% 14.39%
% of Gross Profit 91.11% 80.92% 87.72%
Research & Development $49.81M $47.60M $33.08M
YoY Change 50.58% 64.71% 36.68%
% of Gross Profit 46.95% 46.78% 40.76%
Depreciation & Amortization $10.17M $9.988M $6.740M
YoY Change 50.88% 59.04% 39.17%
% of Gross Profit 9.58% 9.82% 8.3%
Operating Expenses $146.5M $133.4M $104.3M
YoY Change 40.46% 33.66% 20.63%
Operating Profit -$40.38M -$31.63M -$23.12M
YoY Change 74.68% 55.82% 16.63%
Interest Expense $2.693M -$3.518M $5.394M
YoY Change -50.07% -51.81% 55.81%
% of Operating Profit
Other Income/Expense, Net -$603.0K $0.00 -$1.068M
YoY Change -43.54% 138.93%
Pretax Income -$43.56M -$44.23M -$29.48M
YoY Change 47.76% 58.51% 29.99%
Income Tax $1.436M $400.0K $363.0K
% Of Pretax Income
Net Earnings -$45.00M -$44.63M -$29.85M
YoY Change 50.78% 54.41% 30.19%
Net Earnings / Revenue -28.59% -29.43% -25.41%
Basic Earnings Per Share -$0.78 -$0.56
Diluted Earnings Per Share -$0.78 -$784.9K -$0.56
COMMON SHARES
Basic Shares Outstanding 57.72M shares 56.47M shares 52.90M shares
Diluted Shares Outstanding 57.72M shares 52.90M shares

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $234.5M $223.4M $605.8M
YoY Change -61.29% -28.5% 151.58%
Cash & Equivalents $141.4M $164.6M $503.8M
Short-Term Investments $93.16M $58.85M $102.0M
Other Short-Term Assets $69.04M $63.21M $51.50M
YoY Change 34.05% 28.22% 38.81%
Inventory
Prepaid Expenses
Receivables $107.3M $146.1M $76.70M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $410.9M $432.7M $734.1M
YoY Change -44.03% -8.6% 114.44%
LONG-TERM ASSETS
Property, Plant & Equipment $49.80M $50.23M $51.14M
YoY Change -2.61% -5.44% 2.13%
Goodwill $515.3M $515.3M $253.3M
YoY Change 103.43% 141.22% 158.76%
Intangibles $108.2M $111.6M $52.71M
YoY Change 105.37% 151.92% 89.14%
Long-Term Investments $28.30M $34.07M $11.10M
YoY Change 154.91% 237.31% -13.28%
Other Assets $72.12M $68.38M $55.40M
YoY Change 30.18% 33.04% 39.2%
Total Long-Term Assets $863.0M $863.3M $488.6M
YoY Change 76.61% 96.34% 67.71%
TOTAL ASSETS
Total Short-Term Assets $410.9M $432.7M $734.1M
Total Long-Term Assets $863.0M $863.3M $488.6M
Total Assets $1.274B $1.296B $1.223B
YoY Change 4.19% 41.93% 92.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.16M $3.521M $4.296M
YoY Change 183.12% -8.78% -57.3%
Accrued Expenses $56.50M $82.62M $47.81M
YoY Change 18.19% 33.96% 80.5%
Deferred Revenue $378.3M $372.1M $282.2M
YoY Change 34.05% 33.56% 28.63%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $459.6M $468.7M $343.7M
YoY Change 33.71% 32.5% 29.77%
LONG-TERM LIABILITIES
Long-Term Debt $813.0M $812.1M $855.7M
YoY Change -4.99% 114.49% 355.4%
Other Long-Term Liabilities $13.25M $17.34M $2.175M
YoY Change 509.33% 701.39% 64.15%
Total Long-Term Liabilities $13.25M $17.34M $2.175M
YoY Change 509.33% 701.39% 64.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $459.6M $468.7M $343.7M
Total Long-Term Liabilities $13.25M $17.34M $2.175M
Total Liabilities $1.410B $1.422B $1.304B
YoY Change 8.17% 68.97% 133.94%
SHAREHOLDERS EQUITY
Retained Earnings -$781.0M -$736.0M -$619.5M
YoY Change 26.07% 19.24% 14.44%
Common Stock $582.0K $577.0K $551.0K
YoY Change 5.63% 10.54% 9.33%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.764M $4.764M $4.764M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares 486.8K shares 486.8K shares 486.8K shares
Shareholders Equity -$136.6M -$126.0M -$81.23M
YoY Change
Total Liabilities & Shareholders Equity $1.274B $1.296B $1.223B
YoY Change 4.19% 41.93% 92.95%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income -$45.00M -$44.63M -$29.85M
YoY Change 50.78% 54.41% 30.19%
Depreciation, Depletion And Amortization $10.17M $9.988M $6.740M
YoY Change 50.88% 59.04% 39.17%
Cash From Operating Activities $10.40M $4.688M $20.60M
YoY Change -49.49% 708.28% -385.45%
INVESTING ACTIVITIES
Capital Expenditures $3.053M -$6.867M $972.0K
YoY Change 214.09% -18.25% -64.73%
Acquisitions $0.00 $49.72M
YoY Change -100.0%
Other Investing Activities $0.00 -$10.62M $1.500M
YoY Change -100.0% -81.5%
Cash From Investing Activities -$35.91M -$17.49M -$18.44M
YoY Change 94.7% -73.43% -121.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.500M
YoY Change 36.36%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $3.208M -49.29M $328.6M
YoY Change -99.02% 3497.59% 9638.35%
NET CHANGE
Cash From Operating Activities $10.40M 4.688M $20.60M
Cash From Investing Activities -$35.91M -17.49M -$18.44M
Cash From Financing Activities $3.208M -49.29M $328.6M
Net Change In Cash -$23.10M -62.09M $330.2M
YoY Change -107.0% -6.79% 307.58%
FREE CASH FLOW
Cash From Operating Activities $10.40M $4.688M $20.60M
Capital Expenditures $3.053M -$6.867M $972.0K
Free Cash Flow $7.350M $11.56M $19.62M
YoY Change -62.54% 28.67% -296.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001560327
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2020 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-37496
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
RAPID7, INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-2423994
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
120 Causeway Street
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Boston,
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02114
CY2022Q1 dei City Area Code
CityAreaCode
617
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
247-1717
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2022Q1 dei Trading Symbol
TradingSymbol
RPD
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
58264489 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141365000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
164582000 USD
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
93155000 USD
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
58850000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1879000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1978000 USD
CY2022Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
107320000 USD
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
146094000 USD
CY2022Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
30984000 USD
CY2021Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
29974000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
38051000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33236000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
410875000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
432736000 USD
CY2022Q1 us-gaap Long Term Investments
LongTermInvestments
28295000 USD
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
34068000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49804000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50225000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
89196000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
83751000 USD
CY2022Q1 us-gaap Deferred Costs
DeferredCosts
59121000 USD
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
57191000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
515333000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
515258000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
108246000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
111591000 USD
CY2022Q1 us-gaap Other Assets
OtherAssets
13000000 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
11191000 USD
CY2022Q1 us-gaap Assets
Assets
1273870000 USD
CY2021Q4 us-gaap Assets
Assets
1296011000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
12163000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3521000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
56502000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
82620000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11336000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9630000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
378338000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
372067000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1264000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
842000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
459603000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
468680000 USD
CY2022Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
812995000 USD
CY2021Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
812063000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
93954000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
90865000 USD
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
30616000 USD
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
33056000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13253000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17342000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
1410421000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
1422006000 USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58728035 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58181816 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58241227 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57695008 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
582000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
577000 USD
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
486808 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
486808 shares
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
4764000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4764000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
650710000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
615032000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2052000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-812000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-781027000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-736028000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-136551000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-125995000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1273870000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1296011000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
157384000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117451000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16220000 USD
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
51289000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
36289000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
106095000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
81162000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49812000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33080000 USD
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
75146000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
54978000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21516000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
146474000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
104278000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-40379000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-23116000 USD
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
112000 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
96000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
2693000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
5394000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-603000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1068000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43563000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29482000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1436000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
363000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44999000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-29845000 USD
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57724821 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57724821 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52904881 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52904881 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44999000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-29845000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-898000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-129000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-316000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
204000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-582000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-333000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-658000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-9000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1240000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-342000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46239000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30187000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44999000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-136551000 USD
CY2021Q1 rp Adjustments To Additional Paid In Capital Vesting Of Restricted Stock Units
AdjustmentsToAdditionalPaidInCapitalVestingOfRestrictedStockUnits
0 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-125995000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32475000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
5710000 USD
CY2022Q1 rp Adjustments To Additional Paid In Capital Vesting Of Restricted Stock Units
AdjustmentsToAdditionalPaidInCapitalVestingOfRestrictedStockUnits
0 USD
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3461000 USD
CY2022Q1 rp Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
959000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1240000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
71536000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22284000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4467000 USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3324000 USD
CY2021Q1 rp Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
1418000 USD
CY2021Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
76020000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-2698000 USD
CY2021Q1 rp Stock Issued During Period Value Inducement Of Convertible Securities
StockIssuedDuringPeriodValueInducementOfConvertibleSecurities
2740000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-342000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-29845000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-81225000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44999000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-29845000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10169000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6740000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
979000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
658000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
28922000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
20862000 USD
CY2022Q1 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0 USD
CY2021Q1 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
2740000 USD
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-526000 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1404000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-36327000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-34414000 USD
CY2022Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
2939000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
1956000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6556000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
136000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8673000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
550000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-24048000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-15429000 USD
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3830000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
987000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-481000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-394000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10403000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20595000 USD
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
49720000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3053000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
972000 USD
CY2022Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
3522000 USD
CY2021Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1758000 USD
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
32136000 USD
CY2021Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
6394000 USD
CY2022Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2800000 USD
CY2021Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
41900000 USD
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1500000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35911000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18444000 USD
CY2022Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2021Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
587100000 USD
CY2022Q1 rp Payments For Option Indexedto Issuers Equity
PaymentsForOptionIndexedtoIssuersEquity
0 USD
CY2021Q1 rp Payments For Option Indexedto Issuers Equity
PaymentsForOptionIndexedtoIssuersEquity
76020000 USD
CY2022Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2021Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
182647000 USD
CY2022Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
0 USD
CY2021Q1 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
2431000 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3461000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3324000 USD
CY2022Q1 rp Proceeds From Issuance Of Employee Stock Purchase Plan
ProceedsFromIssuanceOfEmployeeStockPurchasePlan
5710000 USD
CY2021Q1 rp Proceeds From Issuance Of Employee Stock Purchase Plan
ProceedsFromIssuanceOfEmployeeStockPurchasePlan
4467000 USD
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
959000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1427000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3208000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
328572000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-800000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-500000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23100000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
330223000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165017000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
173617000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141917000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
503840000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
750000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
1438000 USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
15000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
64000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141365000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
503804000 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
552000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
36000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141917000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
503840000 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The management estimates include, but are not limited to the determination of the estimated economic life of perpetual licenses for revenue recognition, the determination of standalone selling prices in revenue transactions with multiple performance obligations, the estimated period of benefit for deferred contract acquisition and fulfillment costs, the useful lives and recoverability of long-lived assets, the valuation for credit losses, the valuation of stock-based compensation, the fair value of assets acquired and liabilities assumed in business combinations, the incremental borrowing rate for operating leases and the valuation for deferred tax assets. We base our estimates on historical experience and on various other assumptions that we believe are reasonable. Actual results could differ from those estimates. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has resulted in a sustained global slowdown of economic activity that has decreased demand for a broad variety of goods and services, including from our customers. While we have not experienced significant disruptions from the COVID-19 pandemic during the three months ended March 31, 2022, we are unable to accurately predict the extent to which the ongoing COVID-19 pandemic may impact our business, results of operations and financial condition going forward. Estimates and assumptions about future events and their effects cannot be determined with certainty and therefore require the exercise of judgment. As of the date of issuance of these financial statements, we are not aware of any specific event or circumstance that would require us to update our estimates, assumptions and judgments or revise the carrying value of our assets or liabilities. These estimates may change as new events occur and additional information is obtained and will be recognized in the consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to our financial statements.</span></div>
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
157384000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117451000 USD
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
137300000 USD
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
101900000 USD
CY2022Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1100000 USD
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1200000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
428110000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
129865000 USD
CY2022Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 reportingUnit
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
122172000 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
722000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
121450000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
92982000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
64000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
92918000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
515300000 USD
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
84999000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
82222000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35195000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31997000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49804000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50225000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
3300000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
3000000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
515300000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
515258000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
515333000 USD
CY2022Q1 rp Acquired Finite Lived Intangible Assets Gross
AcquiredFiniteLivedIntangibleAssetsGross
137174000 USD
CY2022Q1 rp Acquired Finite Lived Intangible Assets Accumulated Amortization
AcquiredFiniteLivedIntangibleAssetsAccumulatedAmortization
49405000 USD
CY2022Q1 rp Acquired Finite Lived Intangible Assets Net
AcquiredFiniteLivedIntangibleAssetsNet
87769000 USD
CY2021Q4 rp Acquired Finite Lived Intangible Assets Gross
AcquiredFiniteLivedIntangibleAssetsGross
137174000 USD
CY2021Q4 rp Acquired Finite Lived Intangible Assets Accumulated Amortization
AcquiredFiniteLivedIntangibleAssetsAccumulatedAmortization
43682000 USD
CY2021Q4 rp Acquired Finite Lived Intangible Assets Net
AcquiredFiniteLivedIntangibleAssetsNet
93492000 USD
CY2022Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
166552000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
58306000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
108246000 USD
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
163031000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
51440000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
111591000 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6900000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3700000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
19395000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
23111000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
18587000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
16076000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
12478000 USD
CY2022Q1 rp Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
5206000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
94853000 USD
CY2022Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
13400000 USD
CY2022Q1 rp Lessee Operating Lease Termination Period
LesseeOperatingLeaseTerminationPeriod
P5Y6M
CY2022Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
5013000 USD
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
3766000 USD
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
391000 USD
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
165000 USD
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
2385000 USD
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1463000 USD
CY2022Q1 us-gaap Lease Cost
LeaseCost
7789000 USD
CY2021Q1 us-gaap Lease Cost
LeaseCost
5394000 USD
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y1M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y2M12D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.061
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.062
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
3128000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
4147000 USD
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8864000 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
152000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
12812000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
16600000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
18757000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
17947000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
16551000 USD
CY2022Q1 rp Lessee Operating Lease Liability To Be Paid Due After Year Four
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
49066000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
131733000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
26443000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
105290000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28922000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20862000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1411387 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.74
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y4M24D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
150951000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
98783 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.71
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8847000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1312604 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.81
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y2M12D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
131818000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1312604 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.81
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y2M12D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
131818000 USD
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44999000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-29845000 USD
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57724821 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57724821 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52904881 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52904881 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15122283 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21028017 shares
CY2018Q4 us-gaap Loss Contingency Patents Allegedly Infringed Number
LossContingencyPatentsAllegedlyInfringedNumber
7 patent
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q1 us-gaap Revenues
Revenues
157384000 USD
CY2021Q1 us-gaap Revenues
Revenues
117451000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49804000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50225000 USD

Files In Submission

Name View Source Status
0001560327-22-000050-index-headers.html Edgar Link pending
0001560327-22-000050-index.html Edgar Link pending
0001560327-22-000050.txt Edgar Link pending
0001560327-22-000050-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q1202210-qexx311.htm Edgar Link pending
q1202210-qexx312.htm Edgar Link pending
q1202210-qexx321.htm Edgar Link pending
q1202210-qexx322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
rp-20220331.htm Edgar Link pending
rp-20220331.xsd Edgar Link pending
rp-20220331_cal.xml Edgar Link unprocessable
rp-20220331_def.xml Edgar Link unprocessable
rp-20220331_htm.xml Edgar Link completed
rp-20220331_lab.xml Edgar Link unprocessable
rp-20220331_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending